Skip to main content
Top
Published in: Journal of General Internal Medicine 7/2012

01-07-2012 | Original Research

Trajectories of Drug Use and Mortality Outcomes Among Adults Followed Over 18 Years

Authors: Stefan G. Kertesz, MD, MSc, Yulia Khodneva, MD, MPH, Joshua Richman, MD, PhD, Jalie A. Tucker, PhD, MPH, Monika M. Safford, MD, Bobby Jones, PhD, Joseph Schumacher, PhD, Mark J. Pletcher, MD, MPH

Published in: Journal of General Internal Medicine | Issue 7/2012

Login to get access

ABSTRACT

BACKGROUND

For adults in general population community settings, data regarding long-term course and outcomes of illicit drug use are sparse, limiting the formulation of evidence-based recommendations for drug use screening of adults in primary care.

OBJECTIVE

To describe trajectories of three illicit drugs (cocaine, opioids, amphetamines) among adults in community settings, and to assess their relation to all-cause mortality.

DESIGN

Longitudinal cohort, 1987/88 – 2005/06.

SETTING

Community-based recruitment from four cities (Birmingham, Chicago, Oakland, Minneapolis).

PARTICIPANTS

Healthy adults, balanced for race (black and white) and gender were assessed for drug use from 1987/88—2005/06, and for mortality through 12/31/2008 (n = 4301)

MEASUREMENTS

Use of cocaine, amphetamines, and opioids (last 30 days) was queried in the following years: 1987/88, 1990/91, 1992/93, 1995/96, 2000/01, 2005/06. Survey-based assessment of demographics and psychosocial characteristics. Mortality over 18 years.

RESULTS

Trajectory analysis identified four groups: Nonusers (n = 3691, 85.8%), Early Occasional Users (n = 340, 7.9%), Persistent Occasional Users (n = 160, 3.7%), and Early Frequent/Later Occasional Users (n = 110, 2.6%). Trajectories conformed to expected patterns regarding demographics, other substance use, family background and education. Adjusting for demographics, baseline health status, health behaviors (alcohol, tobacco), and psychosocial characteristics, Early Frequent/Later Occasional Users had greater all-cause mortality (Hazard Ratio, HR = 4.94, 95% CI = 1.58–15.51, p = 0.006).

LIMITATIONS

Study is restricted to three common drugs, and trajectory analyses represent statistical approximations rather than identifiable “types”. Causal inferences are tentative.

CONCLUSIONS

Four trajectories describe illicit drug use from young adulthood to middle age. Two trajectories, representing over one third of adult users, continued use into middle age. These persons were more likely to continue harmful risk behaviors such as smoking, and more likely to die.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chen K, Kandel DB. The natural history of drug use from adolescence to the mid-thirties in a general population sample. Am J Public Health. 1995;85(1):41–7.PubMedCrossRef Chen K, Kandel DB. The natural history of drug use from adolescence to the mid-thirties in a general population sample. Am J Public Health. 1995;85(1):41–7.PubMedCrossRef
2.
go back to reference Bachman JG, O’Malley PM, Schulenberg JE, Johnston LD, Bryant AL, Merline AC. The decline of substance use in young adulthood: changes in social activities, roles, and beliefs. Mahwah: Erlbaum; 2002. Bachman JG, O’Malley PM, Schulenberg JE, Johnston LD, Bryant AL, Merline AC. The decline of substance use in young adulthood: changes in social activities, roles, and beliefs. Mahwah: Erlbaum; 2002.
3.
go back to reference Office of Applied Studies SAaMHSA. Results from the 2009 National Survey on Drug Use and Health: detailed tables. Rockville, MD; 2010. Office of Applied Studies SAaMHSA. Results from the 2009 National Survey on Drug Use and Health: detailed tables. Rockville, MD; 2010.
4.
go back to reference Substance Abuse and Mental Health Services Administration, Office of Applied Studies. An examination of trends in illicit drug use among adults aged 50 to 59 in the United States. Rockville: OAS Data Review; 2009. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. An examination of trends in illicit drug use among adults aged 50 to 59 in the United States. Rockville: OAS Data Review; 2009.
5.
go back to reference Colliver JD, Compton WM, Gfroerer JC, Condon T. Projecting drug use among aging baby boomers in 2020. Ann Epidemiol. 2006;16(4):257–65.PubMedCrossRef Colliver JD, Compton WM, Gfroerer JC, Condon T. Projecting drug use among aging baby boomers in 2020. Ann Epidemiol. 2006;16(4):257–65.PubMedCrossRef
6.
go back to reference U.S. Preventive Services Task Force. Screening for illicit drug Use: U.S. preventive services task force recommendation statement. Rockville: Agency for Healthcare Research and Quality; 2008. U.S. Preventive Services Task Force. Screening for illicit drug Use: U.S. preventive services task force recommendation statement. Rockville: Agency for Healthcare Research and Quality; 2008.
7.
go back to reference Andreasson S, Allebeck P. Cannabis and mortality among young men: a longitudinal study of Swedish conscripts. Scan J Soc Med. 1990;18(1):9–15. Andreasson S, Allebeck P. Cannabis and mortality among young men: a longitudinal study of Swedish conscripts. Scan J Soc Med. 1990;18(1):9–15.
8.
go back to reference Friedman GD, Cutter GR, Donahue RP, et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol. 1988;41(11):1105–16.PubMedCrossRef Friedman GD, Cutter GR, Donahue RP, et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol. 1988;41(11):1105–16.PubMedCrossRef
9.
go back to reference Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010;6:109–38.PubMedCrossRef Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010;6:109–38.PubMedCrossRef
10.
go back to reference Golub A, Johnson BD. Variation in youthful risks of progression from alcohol and tobacco to marijuana and to hard drugs across generations. Am J Public Health. 2001;91(2):225–32.PubMedCrossRef Golub A, Johnson BD. Variation in youthful risks of progression from alcohol and tobacco to marijuana and to hard drugs across generations. Am J Public Health. 2001;91(2):225–32.PubMedCrossRef
11.
go back to reference Hser YI, Huang D, Brecht ML, Li L, Evans E. Contrasting trajectories of heroin, cocaine, and methamphetamine use. J Addict Dis. 2008;27(3):13–21.PubMedCrossRef Hser YI, Huang D, Brecht ML, Li L, Evans E. Contrasting trajectories of heroin, cocaine, and methamphetamine use. J Addict Dis. 2008;27(3):13–21.PubMedCrossRef
12.
go back to reference Kertesz SG, Pletcher MJ, Safford M, et al. Illicit drug use in young adults and subsequent decline in general health: the coronary artery risk development in young adults (CARDIA) study. Drug Alcohol Depend. 2007;88(2–3):224–33.PubMedCrossRef Kertesz SG, Pletcher MJ, Safford M, et al. Illicit drug use in young adults and subsequent decline in general health: the coronary artery risk development in young adults (CARDIA) study. Drug Alcohol Depend. 2007;88(2–3):224–33.PubMedCrossRef
13.
go back to reference Hughes GH, Cutter G, Donahue R, et al. Recruitment in the coronary artery disease risk development in young adults (CARDIA) study. Control Clin Trials. 1987;8(4 Suppl):68S–73.PubMedCrossRef Hughes GH, Cutter G, Donahue R, et al. Recruitment in the coronary artery disease risk development in young adults (CARDIA) study. Control Clin Trials. 1987;8(4 Suppl):68S–73.PubMedCrossRef
14.
go back to reference Substance Abuse and Mental Health Services Administration, Office of Applied Studies. National household survey on drug abuse: public release codebook. Rockville: U.S. Department of Health and Human Services; 1985. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. National household survey on drug abuse: public release codebook. Rockville: U.S. Department of Health and Human Services; 1985.
15.
go back to reference Berkman LF, Syme SL. Social networks, host resistance, and mortality: a nine-year follow-up study of Alameda County residents. Am J Epidemiol. 1979;109(2):186–204.PubMed Berkman LF, Syme SL. Social networks, host resistance, and mortality: a nine-year follow-up study of Alameda County residents. Am J Epidemiol. 1979;109(2):186–204.PubMed
16.
go back to reference Knox SS, Siegmund KD, Weidner G, Ellison RC, Adelman A, Paton C. Hostility, social support, and coronary heart disease in the national heart, lung, and blood institute family heart study. Am J Cardiol. 1998;82(10):1192–6.PubMedCrossRef Knox SS, Siegmund KD, Weidner G, Ellison RC, Adelman A, Paton C. Hostility, social support, and coronary heart disease in the national heart, lung, and blood institute family heart study. Am J Cardiol. 1998;82(10):1192–6.PubMedCrossRef
17.
go back to reference Spielberger CD. Manual for the State-Trait Anxiety Inventory (STAI). Palo Alto: Consulting Psychologists Press; 1983. Spielberger CD. Manual for the State-Trait Anxiety Inventory (STAI). Palo Alto: Consulting Psychologists Press; 1983.
18.
go back to reference Repetti RL, Taylor SE, Seeman TE. Risky families: family social environments and the mental and physical health of offspring. Psychol Bull. 2002;128(2):330–66.PubMedCrossRef Repetti RL, Taylor SE, Seeman TE. Risky families: family social environments and the mental and physical health of offspring. Psychol Bull. 2002;128(2):330–66.PubMedCrossRef
19.
go back to reference Taylor SE, Lerner JS, Sage RM, Lehman BJ, Seeman TE. Early environment, emotions, responses to stress, and health. J Pers. 2004;72(6):1365–93.PubMedCrossRef Taylor SE, Lerner JS, Sage RM, Lehman BJ, Seeman TE. Early environment, emotions, responses to stress, and health. J Pers. 2004;72(6):1365–93.PubMedCrossRef
20.
go back to reference Pletcher MJ, Hulley BJ, Houston T, Kiefe CI, Benowitz N, Sidney S. Menthol cigarettes, smoking cessation, atherosclerosis, and pulmonary function: the coronary artery risk development in young adults (CARDIA) study. Arch Intern Med. 2006;166(17):1915–22.PubMedCrossRef Pletcher MJ, Hulley BJ, Houston T, Kiefe CI, Benowitz N, Sidney S. Menthol cigarettes, smoking cessation, atherosclerosis, and pulmonary function: the coronary artery risk development in young adults (CARDIA) study. Arch Intern Med. 2006;166(17):1915–22.PubMedCrossRef
21.
go back to reference Pletcher MJ, Varosy P, Kiefe CI, Lewis CE, Sidney S, Hulley SB. Alcohol consumption, binge drinking, and early coronary calcification: findings from the coronary artery risk development in young adults (CARDIA) study. Am J Epidemiol. 2005;161(5):423–33.PubMedCrossRef Pletcher MJ, Varosy P, Kiefe CI, Lewis CE, Sidney S, Hulley SB. Alcohol consumption, binge drinking, and early coronary calcification: findings from the coronary artery risk development in young adults (CARDIA) study. Am J Epidemiol. 2005;161(5):423–33.PubMedCrossRef
22.
go back to reference Goldberg D. World Health Organization Guide to Mental Health in Primary Care. London: WHO Collaborating Centre for Research and Training for Mental Health; 2000. Goldberg D. World Health Organization Guide to Mental Health in Primary Care. London: WHO Collaborating Centre for Research and Training for Mental Health; 2000.
24.
go back to reference Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psych Meas. 1977;1:385–401.CrossRef Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psych Meas. 1977;1:385–401.CrossRef
25.
go back to reference Iribarren C, Jacobs DR, Kiefe CI, et al. Causes and demographic, medical, lifestyle and psychosocial predictors of premature mortality: the CARDIA study. Soc Sci Med. 2005;60(3):471–82.PubMedCrossRef Iribarren C, Jacobs DR, Kiefe CI, et al. Causes and demographic, medical, lifestyle and psychosocial predictors of premature mortality: the CARDIA study. Soc Sci Med. 2005;60(3):471–82.PubMedCrossRef
26.
go back to reference Nagin DS. Group-based modeling of development. Cambridge: Harvard University Press; 2005. Nagin DS. Group-based modeling of development. Cambridge: Harvard University Press; 2005.
27.
go back to reference Elder GH Jr. The life course as developmental theory. Child Dev. 1998;69(1):1–12.PubMed Elder GH Jr. The life course as developmental theory. Child Dev. 1998;69(1):1–12.PubMed
29.
go back to reference Jones BL, Nagin DS. Advances in group-based trajectory modeling and an SAS procedure for estimating them. Sociol Methods Res. 2007;35(4):542–71.CrossRef Jones BL, Nagin DS. Advances in group-based trajectory modeling and an SAS procedure for estimating them. Sociol Methods Res. 2007;35(4):542–71.CrossRef
30.
go back to reference Schulenberg JE, Merline AC, Johnston LD, O’Malley PM, Bachman JG, Laetz VB. Trajectories of marijuana use during the transition to adulthood: the big picture based on national panel data. J Drug Issues. 2005;35(2):255–79.PubMedCrossRef Schulenberg JE, Merline AC, Johnston LD, O’Malley PM, Bachman JG, Laetz VB. Trajectories of marijuana use during the transition to adulthood: the big picture based on national panel data. J Drug Issues. 2005;35(2):255–79.PubMedCrossRef
31.
go back to reference Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Substance Use among Black Adults. Rockville, MD; 2010. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Substance Use among Black Adults. Rockville, MD; 2010.
32.
go back to reference Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.[see comment]. Arch Gen Psychiatry. 2005;62(6):617–27.PubMedCrossRef Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.[see comment]. Arch Gen Psychiatry. 2005;62(6):617–27.PubMedCrossRef
33.
go back to reference Falck RS, Wang J, Carlson RG. Crack cocaine trajectories among users in a midwestern American city. Addiction. 2007;102(9):1421–31.PubMedCrossRef Falck RS, Wang J, Carlson RG. Crack cocaine trajectories among users in a midwestern American city. Addiction. 2007;102(9):1421–31.PubMedCrossRef
34.
go back to reference Office of Applied Studies. 1998 National Household Survey on Drug Abuse: Summary Tables. Prevalence Estimates, standard errors, and p-values (Vols. 1& 2). Substance Abuse and Mental Health Services Administration; 1999. Office of Applied Studies. 1998 National Household Survey on Drug Abuse: Summary Tables. Prevalence Estimates, standard errors, and p-values (Vols. 1& 2). Substance Abuse and Mental Health Services Administration; 1999.
35.
go back to reference United States Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies. National Survey on Drug Use and Health. 2009-12-16 ed. Ann Arbor, MI: Inter-University Consortium for Political and Social Research [distributor]; 2009 [Computer file]. United States Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies. National Survey on Drug Use and Health. 2009-12-16 ed. Ann Arbor, MI: Inter-University Consortium for Political and Social Research [distributor]; 2009 [Computer file].
36.
go back to reference Hall BH, Mairesse J, Turner L. Identifying age, cohort and period effects in scientific research productivity: discussion and illustration using simulated and actual data on French physicists. Econ Innov New Technol. 2007;15(4–5):391–413. Hall BH, Mairesse J, Turner L. Identifying age, cohort and period effects in scientific research productivity: discussion and illustration using simulated and actual data on French physicists. Econ Innov New Technol. 2007;15(4–5):391–413.
37.
go back to reference Nagin DS. Analyzing developmental trajectories: a semiparametric group-based approach. Psychol Meth. 1999;4(2):139–57.CrossRef Nagin DS. Analyzing developmental trajectories: a semiparametric group-based approach. Psychol Meth. 1999;4(2):139–57.CrossRef
38.
go back to reference United States Preventive Services Task Force. Screening for illicit drug use topic page. Rockville: Agency for Healthcare Research and Quality; 2008. United States Preventive Services Task Force. Screening for illicit drug use topic page. Rockville: Agency for Healthcare Research and Quality; 2008.
39.
go back to reference World Health Organization. The alcohol, smoking and substance involvement screening test (ASSIST): development, reliability and feasibility. Addiction. 2002;97(9):1183–94.CrossRef World Health Organization. The alcohol, smoking and substance involvement screening test (ASSIST): development, reliability and feasibility. Addiction. 2002;97(9):1183–94.CrossRef
40.
go back to reference Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. A single-question screening test for drug use in primary care. Arch Intern Med. 2010;170(13):1155–60.PubMedCrossRef Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. A single-question screening test for drug use in primary care. Arch Intern Med. 2010;170(13):1155–60.PubMedCrossRef
Metadata
Title
Trajectories of Drug Use and Mortality Outcomes Among Adults Followed Over 18 Years
Authors
Stefan G. Kertesz, MD, MSc
Yulia Khodneva, MD, MPH
Joshua Richman, MD, PhD
Jalie A. Tucker, PhD, MPH
Monika M. Safford, MD
Bobby Jones, PhD
Joseph Schumacher, PhD
Mark J. Pletcher, MD, MPH
Publication date
01-07-2012
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 7/2012
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-011-1975-3

Other articles of this Issue 7/2012

Journal of General Internal Medicine 7/2012 Go to the issue

Innovation and Improvement: Improvement Happens

Improvement Happens: Doctors Talk About the Medical Home

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.